Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Capital Reinvestment Ratio
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Capital Reinvestment Ratio of 0.14x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥486.04 Million) in capital expenditures (CN¥67.11 Million). See Shanghai Shyndec Pharmaceutical Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Shyndec Pharmaceutical Co Ltd Capital Reinvestment Ratio (2004–2025)
This chart tracks Shanghai Shyndec Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 22 annual periods.
Annual Capital Reinvestment Ratio for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Shyndec Pharmaceutical Co Ltd from 2004 to 2025. For live market cap and broader valuation context, see how much is Shanghai Shyndec Pharmaceutical Co Ltd worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥1.70 Billion | CN¥263.83 Million | ▲ +59.5% |
| 2024 | 0.10x | CN¥2.26 Billion | CN¥219.77 Million | ▼ -53.1% |
| 2023 | 0.21x | CN¥1.72 Billion | CN¥357.19 Million | ▲ +92.9% |
| 2022 | 0.11x | CN¥2.86 Billion | CN¥307.44 Million | ▼ -65.3% |
| 2021 | 0.31x | CN¥1.68 Billion | CN¥521.44 Million | ▲ +28.1% |
| 2020 | 0.24x | CN¥1.56 Billion | CN¥377.98 Million | ▼ -23.8% |
| 2019 | 0.32x | CN¥1.27 Billion | CN¥403.82 Million | ▲ +32.9% |
| 2018 | 0.24x | CN¥1.67 Billion | CN¥399.40 Million | ▲ +228.8% |
| 2017 | 0.07x | CN¥2.31 Billion | CN¥168.44 Million | ▼ -74.7% |
| 2016 | 0.29x | CN¥838.58 Million | CN¥241.30 Million | ▼ -72.2% |
| 2015 | 1.03x | CN¥226.65 Million | CN¥234.52 Million | ▼ -37.9% |
| 2014 | 1.67x | CN¥258.51 Million | CN¥430.53 Million | ▼ -32.6% |
| 2013 | 2.47x | CN¥207.50 Million | CN¥512.62 Million | ▲ +17.8% |
| 2012 | 2.10x | CN¥193.41 Million | CN¥405.52 Million | ▲ +122.3% |
| 2011 | 0.94x | CN¥136.12 Million | CN¥128.40 Million | ▼ -30.4% |
| 2010 | 1.36x | CN¥115.11 Million | CN¥156.02 Million | ▲ +322.0% |
| 2009 | 0.32x | CN¥97.43 Million | CN¥31.29 Million | ▲ +37.5% |
| 2008 | 0.23x | CN¥58.04 Million | CN¥13.56 Million | ▼ -44.2% |
| 2007 | 0.42x | CN¥82.31 Million | CN¥34.45 Million | ▼ -50.3% |
| 2006 | 0.84x | CN¥73.60 Million | CN¥62.00 Million | ▼ -31.9% |
| 2005 | 1.24x | CN¥57.90 Million | CN¥71.65 Million | ▲ +33.4% |
| 2004 | 0.93x | CN¥17.02 Million | CN¥15.79 Million | — |